These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11156231)

  • 21. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
    Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
    J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An unexpected inverse correlation between soluble epidermal growth factor receptor and interleukin-6 in metastatic malignant melanoma patients.
    Mouawad R; Soubrane C; Rixe O; Khayat D; Spano JP
    Melanoma Res; 2006 Aug; 16(4):335-40. PubMed ID: 16845329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tenascin C and epidermal growth factor receptor as markers of circulating tumoral cells in bladder and colon cancer.
    Gazzaniga P; Nofroni I; Gandini O; Silvestri I; Frati L; Aglianò AM; Gradilone A
    Oncol Rep; 2005 Nov; 14(5):1199-202. PubMed ID: 16211285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
    Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
    Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor receptor [corrected] 2.
    Kiyoshima K; Oda Y; Kinukawa N; Naito S; Tsuneyoshi M
    Hum Pathol; 2005 May; 36(5):522-30. PubMed ID: 15948119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
    Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.
    Foekens JA; Peters HA; Grebenchtchikov N; Look MP; Meijer-van Gelder ME; Geurts-Moespot A; van der Kwast TH; Sweep CG; Klijn JG
    Cancer Res; 2001 Jul; 61(14):5407-14. PubMed ID: 11454684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An elevated serum level of transforming growth factor-beta 1 (TGF-beta 1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma.
    Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(6B):4489-93. PubMed ID: 11205293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum carcinoembryonic antigen level is associated with epidermal growth factor receptor mutations in recurrent lung adenocarcinomas.
    Shoji F; Yoshino I; Yano T; Kometani T; Ohba T; Kouso H; Takenaka T; Miura N; Okazaki H; Maehara Y
    Cancer; 2007 Dec; 110(12):2793-8. PubMed ID: 17941001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
    Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
    Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant p53 protein in the serum of patients with cervical carcinoma: correlation with the level of serum epidermal growth factor receptor and prognostic significance.
    Oh MJ; Choi JH; Lee YH; Lee JK; Hur JY; Park YK; Lee KW; Chough SY; Saw HS
    Cancer Lett; 2004 Jan; 203(1):107-12. PubMed ID: 14670624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protease and antiprotease concentrations in serum and vaginal fluid of patients with carcinoma of the cervix.
    Benítez-Bribiesca L; Freyre-Horta R; Gallegos-Vargas G
    Arch Invest Med (Mex); 1980; 11(4):523-45. PubMed ID: 7011240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of serum sialic acid fractions as markers for carcinoma of the uterine cervix.
    Lagana A; Martinez BP; Marino A; Fago G; Bizzarri M
    Anticancer Res; 1995; 15(5B):2341-6. PubMed ID: 8572649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum epidermal growth factor receptor levels in patients with malignant melanoma.
    Kanemura H; Fukushima S; Yamashita J; Jinnin M; Sakai K; Masuguchi S; Aoi J; Makino T; Inoue Y; Ihn H
    Clin Exp Dermatol; 2013 Mar; 38(2):172-7. PubMed ID: 23397945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of serum epidermal growth factor receptor (EGFR) levels in patients with breast cancer.
    Tas F; Bilgin E; Karabulut S; Duranyildiz D
    Cytokine; 2015 Jan; 71(1):66-70. PubMed ID: 25259789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of transforming growth factor-alpha in the serum of gastric carcinoma patients.
    Choi JH; Kim HC; Lim HY; Nam DK; Kim HS; Yi SY; Shim KS; Han WS
    Oncology; 1999 Oct; 57(3):236-41. PubMed ID: 10545793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum fucose levels in gynaecological disorders including carcinoma cervix.
    Bandlish U; Prabhakar BR; Virmani U
    J Indian Med Assoc; 1991 Sep; 89(9):250-1. PubMed ID: 1795106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phagocytic activity of circulating polymorphonuclear leukocytes from patients with carcinoma of the uterine cervix.
    García-González JE; Rojas-Espinosa O; Aguilar-Santelises M
    Rev Latinoam Microbiol; 1992; 34(2):135-41. PubMed ID: 1345310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copper and zinc levels in serum from patients with abnormalities of the uterine cervix.
    Grail A; Norval M
    Acta Obstet Gynecol Scand; 1986; 65(5):443-7. PubMed ID: 3776486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.